» Articles » PMID: 38792521

Microvascular Density Analysis of Patients with Inactive Systemic Lupus Erythematosus-A Two-Year Follow-Up Optical Coherence Tomography Angiography Study

Abstract

This study aims to investigate the long-term effect of inactive systemic lupus erythematosus (SLE) on the retinal microcirculation measured via optical coherence tomography angiography (OCT-A). Twenty-four eyes of 24 patients with inactive SLE under hydroxychloroquine (HCQ) therapy were included. The OCT-A data (mainly vessel density (VD) and foveal avascular zone (FAZ) data of the superficial and of the deep capillary plexus (SCP, DCP) and the choriocapillaris (CC)) were analyzed and compared between the baseline examination (t) and 2 years later (t). At t, VD in the whole en face SCP and in the CC was notably reduced compared to t (SCP: = 0.001, CC: = 0.013). VD in the DCP, CRT and FAZ area showed no difference at t compared to t (DCP: = 0.128, FAZ: = 0.332, CRT fovea: = 0.296). Correlation analysis between the increase in cumulative doses of HCQ between t and t and the VD of the whole en face SCP did not show any correlation (Spearman r = 0.062 (95% CI -0.367; 0.477). SLE patients demonstrated a decrease in the retinal VD of the SCP and CC over a 2-year period. There was no correlation with the change in cumulative doses of HCQ. These results suggest an ongoing effect of the disease on the retinal and choriocapillary microcirculation.

Citing Articles

Variabilities in Retinal Hemodynamics Across the Menstrual Cycle in Healthy Women Identified Using Optical Coherence Tomography Angiography.

Donica V, Donica A, Pavel I, Danielescu C, Alexa A, Bogdanici C Life (Basel). 2025; 15(1).

PMID: 39859961 PMC: 11766587. DOI: 10.3390/life15010022.

References
1.
Saygin D, Highland K, Tonelli A . Microvascular involvement in systemic sclerosis and systemic lupus erythematosus. Microcirculation. 2018; 26(3):e12440. PMC: 6041191. DOI: 10.1111/micc.12440. View

2.
Petri M, Barr E, Magder L . Development of a systemic lupus erythematosus cardiovascular risk equation. Lupus Sci Med. 2019; 6(1):e000346. PMC: 6827738. DOI: 10.1136/lupus-2019-000346. View

3.
Reiner A, Fitzgerald M, Del Mar N, Li C . Neural control of choroidal blood flow. Prog Retin Eye Res. 2017; 64:96-130. PMC: 5971129. DOI: 10.1016/j.preteyeres.2017.12.001. View

4.
Siso A, Ramos-Casals M, Bove A, Brito-Zeron P, Soria N, Munoz S . Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus. 2008; 17(4):281-8. DOI: 10.1177/0961203307086503. View

5.
Alarcon G, McGwin G, Bertoli A, Fessler B, Calvo-Alen J, Bastian H . Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007; 66(9):1168-72. PMC: 1955128. DOI: 10.1136/ard.2006.068676. View